慢性阻塞性肺疾病多组学的研究成果汇报及展望
Report and Prospects of Multiomics Research on Chronic Obstructive Pulmonary Disease
DOI: 10.12677/ACM.2023.1391992, PDF,   
作者: 杨 哲：青海大学研究生院，青海 西宁；多 杰*：青海省人民医院呼吸与危重症医学科，青海 西宁
关键词: 慢性阻塞性肺病；转录组学；蛋白组学；代谢组学；生物标志物；途径；发病机制；Chronic Obstructive Pulmonary Disease； Transcriptome； Proteomics； Metabolomics； Biomarkers； Pathways； Pathogenesis
摘要: 慢性阻塞性肺病(COPD)是一种常见的异质性呼吸道疾病，其特征是持续性和不完全可逆的气流受限。由于COPD的异质性和表型复杂性，传统的诊断方法只能提供有限的预测结果和治疗信息，不足以进行准确的诊断和评估。随着近年来组学技术的发展，基因组学、蛋白质组学和代谢组学被广泛应用于COPD的研究，为发现生物标志物以诊断和阐明COPD的复杂机制提供了良好的工具。在这篇综述中，我们基于近年来报道的代谢组学、蛋白质组学和转录组学研究，总结了COPD不同的代谢途径、生物标志物、潜在治疗靶点、代谢组学的手段，蛋白标志物，部分基因，以解释COPD的发病机制。最后，提出了COPD研究的前景和挑战。期望这篇综述将为COPD诊断方法的发展和发病机制的阐明提供一些参考。
Abstract: Chronic obstructive pulmonary disease (COPD) is a common heterogeneous respiratory disease characterized by persistent and incompletely reversible airflow restriction. Due to the heterogene-ity and phenotypic complexity of COPD, traditional diagnostic methods can only provide limited predictive results and treatment information, which is insufficient for accurate diagnosis and eval-uation. With the development of omics technology in recent years, Genomics, Proteomics and metabonomics have been widely used in the study of COPD, providing a good tool for discovering biomarkers to diagnose and clarify the complex mechanism of COPD. In this review, based on metabonomics, Proteomics and Transcriptome studies reported in recent years, we summarized the different metabolic pathways, biomarkers, potential therapeutic targets, metabonomics means, protein markers, and some genes of COPD to explain the pathogenesis of COPD. Finally, the pro-spects and challenges of COPD research were proposed. It is expected that this review will provide some reference for the development of diagnostic methods and elucidation of the pathogenesis of COPD.
文章引用：杨哲, 多杰. 慢性阻塞性肺疾病多组学的研究成果汇报及展望[J]. 临床医学进展, 2023, 13(9): 14248-14254. https://doi.org/10.12677/ACM.2023.1391992

参考文献

[1] Jarhyan, P., Hutchinson, A., Khaw, D., Prabhakarana, D. and Mohan, S. (2022) Prevalence of Chronic Obstructive Pulmonary Disease and Chronic Bronchitis in Eight Countries: A Systematic Review and Meta-Analysis. Bulletin of the World Health Organization, 100, 216-230. [Google Scholar] [CrossRef] 
[2] Agustí, A., Celli, B.R., Criner, G.J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M.K., Martinez, F.J., Montes de Oca, M., Mortimer, K., Papi, A., Pavord, I., Roche, N., Salvi, S., Sin, D.D., Singh, D., Stockley, R., López Varela, M.V., Wedzicha, J.A., et al. (2023) Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. The Euro-pean Respiratory Journal, 61, Article ID: 2300239. [Google Scholar] [CrossRef] [PubMed]
[3] 《慢性阻塞性肺疾病诊治指南(2021年修订版)》诊断要点[J]. 实用心脑肺血管病杂志, 2021, 29(6): 134.
[4] Li, C., Wheelock, C., Sköld, C. and Wheelock, Å. (2018) Inte-gration of Multi-Omics Datasets Enables Molecular Classification of COPD. European Respiratory Journal, 51, Article ID: 1701930. [Google Scholar] [CrossRef] [PubMed]
[5] He, J.C., Chuang, P.Y., Ma’Ayan, A. and Iyengar, R. (2012) Systems Biology of Kidney Diseases. Kidney International, 81, 22-39. [Google Scholar] [CrossRef] [PubMed]
[6] Tan, K.C., Ipcho, S.V.S., Trengove, R.D., Oliver, R.P. and Solomon, P.S. (2009) Assessing the Impact of Transcriptomics, Proteomics and Metabolomics on Fungal Phytopathology. Molecular Plant Pathology, 10, 703-715. [Google Scholar] [CrossRef] [PubMed]
[7] Wilmes, A., Limonciel, A., Aschauer, L., et al. (2013) Ap-plication of Integrated Transcriptomic, Proteomic and Metabolomic Profiling for the Delineation of Mechanisms of Drug Induced Cell Stress. Journal of Proteomics, 79, 180-194. [Google Scholar] [CrossRef] [PubMed]
[8] Gehlenborg, N., O’Donoghue, S.I., Baliga, N.S., Goesmann, A., Hibbs, M.A., Kitano, H., Kohlbacher, O., Neuweger, H., Schneider, R., Tenenbaum, D. and Gavin, A.C. (2010) Visual-ization of Omics Data for Systems Biology. Nature Methods, 7, S56-S68. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, H., Zhong, Y., Li, N., et al. (2022) Transcriptomic Analysis and Validation Reveal the Pathogenesis and a Novel Biomarker of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Respiratory Research, 23, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
[10] Zhu, M., Ye, M., Wang, J., Ye, L. and Jin, M. (2020) Construction of Potential miRNA-mRNA Regulatory Network in COPD Plas-ma by Bioinformatics Analysis. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2135-2145. [Google Scholar] [CrossRef] 
[11] He, H.Z., Wang, H.C., Pei, F.Y. and Jiang, M. (2018) MiR-543 Regulates the Development of Chronic Obstructive Pulmonary Disease by Targeting Interleukin-33. Clinical Laboratory, 64, 1199-1205. [Google Scholar] [CrossRef] 
[12] Han, L., Wang, J., Ji, X.B., et al. (2021) Transcriptomics Analysis Identifies the Presence of Upregulated Ribosomal Housekeeping Genes in the Alveolar Macrophages of Pa-tients with Smoking-Induced Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 16, 2653-2664. [Google Scholar] [CrossRef] 
[13] Duan, R., Niu, H., Yu, T., et al. (2020) Identification and Bioinfor-matic Analysis of Circular RNA Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Obstruc-tive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1391-1401. [Google Scholar] [CrossRef] 
[14] Dang, X.M., Qu, X.Y., Wang, W.J., et al. (2017) Bioinformatic Analysis of microRNA and mRNA Regulation in Peripheral Blood Mononuclear Cells of Patients with Chronic Obstruc-tive Pulmonary Disease. Respiratory Research, 18, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[15] Qu, X.Y., Dang, X.M., Wang, W.J., et al. (2018) Long Noncod-ing RNAs and mRNA Regulation in Peripheral Blood Mononuclear Cells of Patients with Chronic Obstructive Pulmo-nary Disease. Mediators of Inflammation, 2018, Article ID: 7501851. [Google Scholar] [CrossRef] [PubMed]
[16] Manzoni, C., Kia, D.A., Vandrovcova, J., et al. (2018) Genome, Tran-scriptome and Proteome: The Rise of Omics Data and Their Integration in Biomedical Sciences. Briefings in Bioinfor-matics, 19, 286-302. [Google Scholar] [CrossRef] [PubMed]
[17] 孟霄, 管艳. 蛋白质组学技术在呼吸系统疾病研究中的应用进展[J]. 解放军医学院学报, 2021, 42(11): 1225-1229.
[18] 帅迪全, 王筠, 李水明, 等. 慢性阻塞性肺疾病不同种类标本的蛋白质组学研究[J]. 国际呼吸杂志, 2019, 39(18): 1412-1417.
[19] Koba, T., Takeda, Y., Narumi, R., et al. (2021) Proteomics of Serum Extracellular Vesicles Identifies a Novel COPD Biomarker, Fibulin-3 from Elastic Fibres. ERJ Open Research, 7, 00658-2020. [Google Scholar] [CrossRef] [PubMed]
[20] Merali, S., Barrero, C.A., Bowler, R.P., et al. (2014) Analysis of the Plasma Proteome in COPD: Novel Low Abundance Proteins Reflect the Severity of Lung Remodeling. COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 177-189. [Google Scholar] [CrossRef] [PubMed]
[21] Kim, S.H., Ahn, H.S., Park, J.S., et al. (2021) A Prote-omics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1497-1508. [Google Scholar] [CrossRef] 
[22] Kammerl, I.E., Hardy, S., Flexeder, C., et al. (2022) Activation of Immune Cell Proteasomes in Peripheral Blood of Smokers and COPD Patients: Implications for Therapy. European Res-piratory Journal, 59, Article ID: 2101798. [Google Scholar] [CrossRef] [PubMed]
[23] Zhou, J., Li, Q., Liu, C., Pang, R. and Yin, Y. (2020) Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmo-nary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 553-565. [Google Scholar] [CrossRef] 
[24] 张海龙, 司一妹. 代谢组学应用于慢性阻塞性肺疾病研究进展[J]. 中医学报, 2020, 35(9): 1913-1917.
[25] Ran, N., Pang, Z., Gu, Y., et al. (2019) An Updated Overview of Metabolom-ic Profile Changes in Chronic Obstructive Pulmonary Disease. Metabolites, 9, Article 111. [Google Scholar] [CrossRef] [PubMed]
[26] Bowler, R.P., Jacobson, S., Cruickshank, C., et al. (2015) Plasma Sphingolipids Associated with Chronic Obstructive Pulmonary Disease Phenotypes. American Journal of Respiratory and Critical Care Medicine, 191, 275-284. [Google Scholar] [CrossRef] 
[27] Huang, Q., Wu, X., Gu, Y., et al. (2022) Detection of the Dis-orders of Glycerophospholipids and Amino Acids Metabolism in Lung Tissue From Male COPD Patients. Frontiers in Molecular Biosciences, 9, Article 839259. [Google Scholar] [CrossRef] [PubMed]
[28] Gai, X., Guo, C., Zhang, L., et al. (2021) Serum Glycerophospho-lipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Frontiers in Physiology, 12, Article 646010. [Google Scholar] [CrossRef] [PubMed]
[29] 赵正阳, 王至婉. 以代谢组学技术为代表的系统生物学技术在慢性阻塞性肺疾病研究中的运用[J]. 中华中医药学刊, 2022, 40(12): 23-26. [Google Scholar] [CrossRef] 
[30] Ubhi, B.K., Riley, J.H., Shaw, P.A., et al. (2012) Metabolic Profiling Detects Biomarkers of Protein Degradation in COPD Patients. European Respiratory Journal, 40, 345-355. [Google Scholar] [CrossRef] [PubMed]
[31] Bahr, T.M., Hughes, G.J., Armstrong, M., et al. (2013) Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology, 49, 316-323. [Google Scholar] [CrossRef] 
[32] 杜孟姣, 钟艳梅, 邓善滨, 等. 盐酸班布特罗改善慢性阻塞性肺疾病模型大鼠的作用机制研究[J]. 中国药房, 2020, 31(5): 564-570.

为你推荐